Institutional Ownership Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT). We have compiled data on the 38 institutions that hold shares in the stock, with a total of 2.62 Million shares, which have been reported (via 13F filing form) to have a value of $19.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
10,344
shares
|
$77,993
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Jain Global LLC
New York, NY |
May 15, 2025 Q1 2025 |
10,154
shares
|
$76,561
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
6,977
shares
|
$52,606
0.0% of portfolio
|
Q1 2025
Added 200.86%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,656
shares
|
$12,486
0.0% of portfolio
|
Q1 2025
Added 2.54%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
1,159
shares
|
$8,738
0.0% of portfolio
|
Q1 2025
Added 1.31%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
1,025
shares
|
$7,728
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
179
shares
|
$1,349
0.0% of portfolio
|
Q4 2024
Reduced 6.77%
|
|
|
Steward Partners Investment Advisory, LLC
|
May 13, 2025 Q1 2025 |
100
shares
|
$754
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|